| Q35564485 | "Blues" ain't good for the heart |
| Q34625323 | A model of psychosocial and cultural antecedents of blood pressure control. |
| Q44503417 | A prospective cohort study investigating readmission, symptom attribution and psychological health within six months of primary percutaneous coronary intervention |
| Q30955590 | A systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future |
| Q37866294 | A topographical map of the causal network of mechanisms underlying the relationship between major depressive disorder and coronary heart disease. |
| Q77853784 | ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stab |
| Q37556437 | Acute Coronary Syndrome and Suicide: A Case-Referent Study |
| Q37030513 | Adaptation and implementation of an evidence-based behavioral medicine program in diverse global settings: The Williams LifeSkills experience |
| Q36824285 | Adverse psychological outcome in women with coronary artery disease |
| Q51062059 | Alexithymia following myocardial infarction: psychometric properties and correlates of the Toronto Alexithymia Scale. |
| Q43198836 | Altered functioning of the executive control circuit in late-life depression: episodic and persistent phenomena. |
| Q43790679 | An association between depressive symptoms and survival in incident dialysis patients |
| Q28377083 | An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline Anti-Depressant Heart Attack Trial |
| Q42615490 | An open-label study of nefazodone treatment of major depression in patients with congestive heart failure |
| Q35743026 | Anaemia and the development of depressive symptoms following acute coronary syndrome: longitudinal clinical observational study |
| Q35066464 | Antidepressant drug discovery in the postgenomic era. |
| Q41428578 | Antidepressant drugs and the cardiovascular system: a comparison of tricylics and selective serotonin reuptake inhibitors and their relevance for the treatment of psychiatric patients with cardiovascular problems |
| Q82619375 | Antidepressant therapy in coronary artery disease |
| Q87474610 | Antidepressant treatment of cytokine-induced mood disorders |
| Q37467525 | Antidepressant use, depression, and survival in patients with heart failure |
| Q50091938 | Antidepressants and the risk of arrhythmia in elderly affected by a previous cardiovascular disease: a real-life investigation from Italy |
| Q24236616 | Antidepressants for depression in physically ill people |
| Q37799171 | Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis |
| Q28195907 | Antiplatelet activity during coadministration of the selective serotonin reuptake inhibitor paroxetine and aspirin in male smokers: a randomized, placebo-controlled, double-blind trial |
| Q51026368 | Anxiety and depression after acute myocardial infarction. |
| Q46447900 | Anxiety and depression after coronary artery bypass graft surgery: most get better, some get worse |
| Q35950406 | Anxiety, depression and psychosocial stress in patients with cardiac events |
| Q81405498 | Anxiety, depression, and heart disease in women |
| Q86719164 | Anxious attachment and psychological distress in cardiac rehabilitation patients |
| Q90418646 | Artificial FLOwering plants in Reducing Anxiety and depressive symptoms following Acute Coronary Syndromes (A-FLORA-ACS): a randomised controlled trial |
| Q37600391 | Assessing depression in cardiac patients: what measures should be considered? |
| Q37776566 | Assessing the Presence and Severity of Depression in Subjects with Comorbid Coronary Heart Disease |
| Q51016447 | Associated daily biosynthesis of cortisol and thromboxane A2: a preliminary report. |
| Q81827401 | Association between fibromyalgia and coronary heart disease and coronary catheterization |
| Q48047177 | Association between major depression and cardiovascular risk: the role of antidepressant medication |
| Q35553009 | Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death |
| Q50954770 | Association of anger proneness, depression and low social support with peripheral arterial disease: the Atherosclerosis Risk in Communities Study. |
| Q38115279 | Association of antidepressant and atypical antipsychotic use with cardiovascular events and mortality in a veteran population. |
| Q37063491 | Association of depression and survival in patients with chronic heart failure over 12 Years |
| Q72064694 | Association of depression witk reduced heart rate variability in coronary artery disease |
| Q35580574 | Association of depression, CD8+ T lymphocytes, and natural killer cell activity: implications for morbidity and mortality in Human immunodeficiency virus disease. |
| Q51088784 | Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation. |
| Q51074217 | Attachment and loss experiences during childhood are associated with adult hostility, depression, and social support. |
| Q37370960 | Attachment anxiety predicts depression and anxiety symptoms following coronary artery bypass graft surgery |
| Q48335258 | Attenuation of post-myocardial infarction depression in rats by n-3 fatty acids or probiotics starting after the onset of reperfusion. |
| Q37062552 | Augmentation treatment in major depressive disorder: focus on aripiprazole |
| Q51976621 | Autobiographical memory and depression in the later age: the bump is a turning point. |
| Q51114708 | Behavioral differences and effects of cardiac rehabilitation in diabetic patients following cardiac events. |
| Q35066557 | Behavioral medicine in the prevention and treatment of cardiovascular disease |
| Q34024116 | Beyond symptomatic improvement:assessing real-world outcomes in patients with major depressive disorder |
| Q64099561 | Bifidobacterium longum R0175 attenuates post-myocardial infarction depressive-like behaviour in rats |
| Q30714232 | Biological risk factors in late life depression |
| Q51012093 | Biomedical and psychosocial predictors of anginal frequency in patients following angioplasty with and without coronary stenting. |
| Q35017378 | Brain, behavior, mental stress, and the neurocardiac interaction |
| Q35236309 | Broken heart: depression in cardiovascular disease |
| Q37622990 | Broken-hearted women: the complex relationship between depression and cardiovascular disease. |
| Q28221337 | C-reactive protein and vulnerability to mental stress-induced myocardial ischemia |
| Q47359978 | Can morbidly obese patients safely lose weight preoperatively? |
| Q53655070 | Cardiac anxiety in patients self-referred for electron beam tomography |
| Q60286826 | Cardiac history, prior depression and personality predict course of depressive symptoms after myocardial infarction |
| Q44685657 | Cardiac parasympathetic dysfunction related to depression in older adults with acute coronary syndromes |
| Q73172543 | Cardiac rehabilitation |
| Q41095044 | Cardiac rehabilitation and secondary prevention after a myocardial event |
| Q51987840 | Cardiac rehabilitation in older coronary patients. |
| Q36077336 | Cardiologic side effects of psychotropic drugs. |
| Q36817568 | Cardiological risk factors for depressive symptoms after a first myocardial infarction. |
| Q52135252 | Cardiopsychiatry. |
| Q37812473 | Cardiovascular Disease and Depression in Women |
| Q37529769 | Cardiovascular abnormalities in patients with major depressive disorder: autonomic mechanisms and implications for treatment. |
| Q34242749 | Cardiovascular disease in persons with depressive and anxiety disorders. |
| Q41758864 | Care for depression in HMO patients aged 65 and older |
| Q82692524 | Care of the adult with congenital heart disease |
| Q24550661 | Case-finding instruments for depression. Two questions are as good as many |
| Q36079658 | Characteristics of contemporary patients discharged from the hospital after an acute coronary syndrome |
| Q36192466 | Cholesterol and lipids in depression: stress, hypothalamo-pituitary-adrenocortical axis, and inflammation/immunity. |
| Q93192444 | Chronic Stress-Related Neural Activity Associates With Subclinical Cardiovascular Disease in Psoriasis: A Prospective Cohort Study |
| Q34324751 | Chronic depression in the elderly: approaches for prevention. |
| Q89081455 | Classical Risk Factors and Inflammatory Biomarkers: One of the Missing Biological Links between Cardiovascular Disease and Major Depressive Disorder |
| Q35374441 | Clinical Psychology and Cardiovascular Disease: An Up-to-Date Clinical Practice Review for Assessment and Treatment of Anxiety and Depression |
| Q35189628 | Clinical and health services relationships between major depression, depressive symptoms, and general medical illness |
| Q43569254 | Clinical and treatment response characteristics of late-life depression associated with vascular disease: a pooled analysis of two multicenter trials with sertraline |
| Q37870585 | Clinical depression and inflammatory risk markers for coronary heart disease |
| Q71592478 | Clinical guidelines. Now or never |
| Q46336435 | Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics |
| Q73311272 | Clinical trials in geriatric disorders |
| Q34506856 | Clinical trials update: The Heart Protection Study, IONA, CARISA, ENRICHD, ACUTE, ALIVE, MADIT II and REMATCH. Impact Of Nicorandil on Angina. Combination Assessment of Ranolazine In Stable Angina. ENhancing Recovery In Coronary Heart Disease patien |
| Q37376724 | Cognition as a therapeutic target in late-life depression: potential for nicotinic therapeutics |
| Q52012925 | Cognitive and somatic symptoms of depression are associated with medical comorbidity in patients after acute myocardial infarction. |
| Q51853484 | Combination of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 reduces post-myocardial infarction depression symptoms and restores intestinal permeability in a rat model. |
| Q78640528 | Combined action of the ACE D- and the G-protein beta3 T-allele in major depression: a possible link to cardiovascular disease? |
| Q35581278 | Combined effects of depressive symptoms and resting heart rate on mortality: the Whitehall II prospective cohort study |
| Q34716007 | Common conditions of the aging male: erectile dysfunction, benign prostatic hyperplasia, cardiovascular disease and depression |
| Q38578643 | Common genetic risk factors for psychiatric and simatic disorders |
| Q43526428 | Comorbid cardiovascular disease and major depression among ethnic and racial groups in the United States |
| Q38717849 | Comorbidities in Heart Failure: Are There Gender Differences? |
| Q34934375 | Comorbidity of depression with other medical diseases in the elderly |
| Q35441481 | Comparing the effectiveness of an enhanced MOtiVational intErviewing InTervention (MOVE IT) with usual care for reducing cardiovascular risk in high risk subjects: study protocol for a randomised controlled trial |
| Q50960489 | Comparison of preoperative characteristics of men and women undergoing coronary artery bypass grafting (the Post Coronary Artery Bypass Graft [CABG] Biobehavioral Study). |
| Q33616538 | Computer-assisted assessment of depression and function in older primary care patients |
| Q40940101 | Consultation-liaison psychiatry and the practice of medicine. The Thomas P. Hackett Award lecture given at the 42nd annual meeting of the Academy of Psychosomatic Medicine, 1995. |
| Q34081687 | Contribution of patient and physician factors to cardiac rehabilitation enrollment: a prospective multilevel study |
| Q34110665 | Contribution of patient and physician factors to cardiac rehabilitation referral: a prospective multilevel study |
| Q44555956 | Coping competence as predictor and moderator of depression among chronic disease patients |
| Q37362296 | Coping styles in heart failure patients with depressive symptoms |
| Q36647940 | Coronary Heart Disease and Emotional Intelligence |
| Q34248128 | Counseling via analogy: improving patient adherence in major depressive disorder |
| Q33860933 | Current concepts in secondary prevention after acute myocardial infarction |
| Q51012096 | Cynical hostility, depressive symptoms, and the expression of inflammatory risk markers for coronary heart disease. |
| Q48377488 | Cytokine mediation of experimental heart failure-induced anhedonia |
| Q37439042 | Cytokine-induced depression during IFN-alpha treatment: the role of IL-6 and sleep quality |
| Q51651195 | Daily stress and social support among women with CAD: results from a 1-year randomized controlled stress management intervention study. |
| Q43914888 | Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression |
| Q47139081 | Demographic and psychological predictors of recovery from coronary artery bypass graft |
| Q52918485 | Depressed mood and subjective health symptoms as predictors of mortality in patients with congestive heart failure: a two-years follow-up study. |
| Q35771906 | Depression after myocardial infarction is a risk factor for declining health related quality of life and increased disability and cardiac complaints at 12 months |
| Q37419673 | Depression and 24-hour urinary cortisol in medical outpatients with coronary heart disease: The Heart and Soul Study |
| Q43422283 | Depression and 5-year mortality in patients with acute myocardial infarction: analysis of the IDACC database. |
| Q35988427 | Depression and Anxiety after Acute Myocardial Infarction Treated by Primary PCI. |
| Q80968712 | Depression and CHD risk: how should we intervene? |
| Q35081694 | Depression and HIV infection: impact on immune function and disease progression. |
| Q40340933 | Depression and all-cause and cardiovascular mortality in patients on haemodialysis: a multinational cohort study |
| Q35049215 | Depression and anxiety and outcomes of coronary artery bypass surgery |
| Q34539677 | Depression and anxiety in older women |
| Q50775871 | Depression and anxiety symptoms affect change in exercise capacity during cardiac rehabilitation. |
| Q35293476 | Depression and associated factors in internal migrant workers in China |
| Q34554332 | Depression and associated physical diseases and symptoms. |
| Q36802104 | Depression and cardiac disease: epidemiology, mechanisms, and diagnosis |
| Q28210833 | Depression and cardiovascular comorbidity |
| Q59215971 | Depression and cardiovascular disease: co-occurrence or shared genetic substrates? |
| Q92070138 | Depression and cardiovascular disease: does antidepressant treatment improve cardiac outcome? |
| Q35189643 | Depression and cardiovascular disease: mechanisms of interaction |
| Q37285362 | Depression and coronary artery disease: the association, mechanisms, and therapeutic implications. |
| Q53131906 | Depression and coronary heart disease. |
| Q41382451 | Depression and coronary heart disease: a review for cardiologists. |
| Q73932678 | Depression and coronary heart disease: observations and questions |
| Q73954779 | Depression and health-care costs during the first year following myocardial infarction |
| Q34515234 | Depression and heart disease: evidence of a link, and its therapeutic implications |
| Q48946171 | Depression and heart rate variability in cardiac rehabilitation patients: exploring the roles of physical activity and fitness |
| Q37419650 | Depression and heart rate variability in patients with stable coronary heart disease: findings from the Heart and Soul Study |
| Q37352589 | Depression and increased mortality in diabetes: unexpected causes of death |
| Q51947833 | Depression and increased myocardial ischemic activity in patients with ischemic heart disease. |
| Q35103458 | Depression and ischemic heart disease: overview of the evidence and treatment implications |
| Q71590675 | Depression and long-term mortality risk in patients with coronary artery disease |
| Q50107221 | Depression and medical illness in late life: report of a symposium |
| Q37419725 | Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study |
| Q74729482 | Depression and mortality following myocardial infarction: the issue of disease severity |
| Q41377520 | Depression and mortality in medically ill older adults |
| Q41564646 | Depression and myocardial infarction. Implications for medical prognosis and options for treatment |
| Q33949053 | Depression and myocardial infarction: relationship between heart and mind |
| Q36078245 | Depression and nonadherence predict mortality in hemodialysis treated end-stage renal disease patients |
| Q34733166 | Depression and prognosis following hospital admission because of acute myocardial infarction |
| Q50866710 | Depression and social support in elderly patients with cardiac disease. |
| Q37599875 | Depression and the cardiovascular system: increasing evidence of a link and therapeutic implications |
| Q37387750 | Depression and the heart |
| Q35586421 | Depression and the heart: a systematic overview of definition, measurement, consequences and treatment of depression in cardiovascular disease |
| Q48560407 | Depression and thyroid axis function in coronary artery disease: impact of cardiac impairment and gender |
| Q34717232 | Depression as a predictor for coronary heart disease. a review and meta-analysis |
| Q34723549 | Depression as a risk factor for adverse outcomes in coronary heart disease |
| Q37143291 | Depression as a risk factor for cardiac events in established coronary heart disease: a review of possible mechanisms |
| Q34959938 | Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms |
| Q43646314 | Depression as a risk factor for mortality after coronary artery bypass surgery |
| Q42928609 | Depression as a risk factor for underuse of mammography |
| Q38984027 | Depression care among depressed adults with and without comorbid substance use disorders in the United States |
| Q49163069 | Depression following myocardial infarction: a one year longitudinal study |
| Q33568470 | Depression following thrombotic cardiovascular events in elderly medicare beneficiaries: risk of morbidity and mortality |
| Q92889399 | Depression in Survivors of Acute Myocardial Infarction |
| Q35189605 | Depression in cardiovascular disease: can the risk be reduced? |
| Q34394768 | Depression in chronic medical illness: the case of coronary heart disease |
| Q77992173 | Depression in coronary heart disease. What is the appropriate diagnostic threshold? |
| Q35236177 | Depression in late life: psychiatric-medical comorbidity |
| Q33958344 | Depression in patients with cardiac disease: a practical review |
| Q53594216 | Depression in patients with cirrhosis. Impact on outcome. |
| Q36982732 | Depression in patients with hypertrophic cardiomyopathy: is there any relation with the risk factors for sudden death? |
| Q35816617 | Depression in the elderly. Tailoring medical therapy to their special needs |
| Q48823447 | Depression is associated with prolonged and complicated recovery following colorectal surgery |
| Q43856919 | Depression predicts failure to complete phase-II cardiac rehabilitation |
| Q33875308 | Depression really does hurt your heart: stress, depression, and cardiovascular disease. |
| Q77491745 | Depression, Hostility, and Social Isolation in Patients with Coronary Artery Disease |
| Q30713666 | Depression, heart rate variability, and acute myocardial infarction |
| Q35189639 | Depression, mortality, and medical morbidity in patients with coronary heart disease |
| Q43491190 | Depression, suicidal ideation, and attempts in black patients with sickle cell disease. |
| Q59132555 | Depressive Symptoms and Complications Early after Acute Myocardial Infarction: Gender Differences |
| Q43482714 | Depressive mood after a cardiac event: gender inequality and participation in rehabilitation programme |
| Q33650132 | Depressive mood is independently related to stroke and cardiovascular events in a community |
| Q48847791 | Depressive symptom dimensions and cardiac prognosis following myocardial infarction: results from the ENRICHD clinical trial |
| Q37419720 | Depressive symptoms and 24-hour urinary norepinephrine excretion levels in patients with coronary disease: findings from the Heart and Soul Study |
| Q43821586 | Depressive symptoms and age-related macular degeneration in older people: the cardiovascular health study |
| Q74194632 | Depressive symptoms and risk of functional decline and death in patients with heart failure |
| Q28078655 | Depressive symptoms are associated with higher rates of readmission or mortality after medical hospitalization: A systematic review and meta-analysis |
| Q78944629 | Depressive symptoms in relation to marital and work stress in women with and without coronary heart disease. The Stockholm Female Coronary Risk Study |
| Q35908879 | Design and methods of the Gentle Cardiac Rehabilitation Study--A behavioral study of tai chi exercise for patients not attending cardiac rehabilitation |
| Q35371621 | Determinants of an impaired quality of life five years after coronary artery bypass surgery. |
| Q53524637 | Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. |
| Q34385688 | Development of mental disorders one year after exposure to psychosocial stressors; a cohort study in primary care patients with a physical complaint. |
| Q42694755 | Development of psychiatric risk evaluation checklist and routine for nurses in a general hospital: ethnographic qualitative study |
| Q37407146 | Diagnosis and treatment of depression in patients with congestive heart failure: a review of the literature |
| Q40602271 | Diagnostic dilemmas presented by patients with anxiety and depression |
| Q45737690 | Dietary interventions with n-3 fatty acids or probiotics targeting post-myocardial infarction depression |
| Q34720379 | Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy |
| Q43072729 | Do antidepressants really work? |
| Q33842166 | Do negative emotions mediate the association between socioeconomic status and health? |
| Q37732309 | Do platelet-derived microparticles play a role in depression, inflammation, and acute coronary syndrome? |
| Q60701227 | Does depression predict more symptoms or more disease? |
| Q34276633 | Does screening for depression in primary care improve outcome? |
| Q47577109 | Does service timing matter for psychological outcomes in cardiac rehabilitation? Insights from the National Audit of Cardiac Rehabilitation |
| Q53556772 | Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina With Aggrastat [tirofiban]] and Determine Cost of Therapy with Invasive or Conservative Strategy)-TIMI 18 trial. |
| Q33756242 | Effect of Depression on Prognosis in Heart Failure |
| Q57211157 | Effect of Escitalopram vs Placebo Treatment for Depression on Long-term Cardiac Outcomes in Patients With Acute Coronary Syndrome: A Randomized Clinical Trial |
| Q37677026 | Effect of depression and sertraline treatment on cardiac function in female nonhuman primates |
| Q74537327 | Effect of intervention for psychological distress on rehospitalization rates in cardiac rehabilitation patients |
| Q35501175 | Effective treatment of depression improves post-myocardial infarction survival |
| Q36998904 | Effects of Exercise and Sertraline on Measures of Coronary Heart Disease Risk in Patients With Major Depression: Results From the SMILE-II Randomized Clinical Trial |
| Q47288912 | Effects of anxiety and depression on heart disease attributions |
| Q53550937 | Effects of cardiac rehabilitation and exercise training programs in women with depression. |
| Q52007391 | Effects of cardiac rehabilitation and exercise training programs on depression in patients after major coronary events. |
| Q51072073 | Effects of depression and anxiety on mortality and quality-of-life 4 months after myocardial infarction. |
| Q48798114 | Effects of depression and anxiety symptoms on cardiac mortality following myocardial infarction: a 2-year follow-up |
| Q35150787 | Effects of depressive symptoms and coronary heart disease and their interactive associations on mortality in middle-aged adults: the Whitehall II cohort study |
| Q79299400 | Effects of exercise and cardiac rehabilitation on cardiovascular outcomes |
| Q36535316 | Effects of exercise and weight loss on depressive symptoms among men and women with hypertension |
| Q50904847 | Effects of expanded cardiac rehabilitation on psychosocial status in coronary artery disease with focus on type D characteristics. |
| Q44413744 | Effects of heavy alcohol consumption on the cardiovascular system may be mediated in part by the influence of alcohol-induced depression on the immune system |
| Q36924981 | Effects of omega-3 fatty acid supplementation on heart rate variability at rest and during acute stress in adults with moderate hypertriglyceridemia |
| Q43151256 | Efficacy and tolerability of antidepressants for treatment of depression in coronary artery disease: a meta-analysis |
| Q38680051 | Efficacy of home-based non-pharmacological interventions for treating depression: a systematic review and network meta-analysis of randomised controlled trials |
| Q34093713 | Efficacy of venlafaxine in geriatric depression |
| Q24248680 | Electroconvulsive therapy for the depressed elderly |
| Q35139506 | Electroconvulsive therapy in the medically ill. |
| Q35977769 | Electronic clinical decision support for management of depression in primary care: a prospective cohort study |
| Q34071255 | Elevated inflammation levels in depressed adults with a history of childhood maltreatment |
| Q50938987 | Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease. |
| Q71751419 | Emotional distress among males with "syndrome X" |
| Q53569708 | Emotional distress before coronary bypass grafting limits the benefits of surgery. |
| Q53450437 | Emotional distress in chronic hepatitis C patients not receiving antiviral therapy. |
| Q48933250 | Emotional triggering and low socio-economic status as determinants of depression following acute coronary syndrome |
| Q36777112 | Enhancing Cardiac Rehabilitation With Stress Management Training: A Randomized, Clinical Efficacy Trial |
| Q52058325 | Enhancing recovery in coronary heart disease (ENRICHD): baseline characteristics. |
| Q73318582 | Enhancing recovery in coronary heart disease patients (ENRICHD): study design and methods. The ENRICHD investigators |
| Q37177100 | Epidemiological and clinical use of GMHAT-PC (Global Mental Health assessment tool - primary care) in cardiac patients |
| Q70820024 | Epidemiology and treatment of post-stroke depression |
| Q35189634 | Epidemiology of comorbid coronary artery disease and depression |
| Q35553004 | Epidemiology, diagnosis, and management of depression in patients with CKD. |
| Q37061162 | Ethnic differences in the treatment of depression in patients with ischemic heart disease |
| Q74484746 | Even minimal symptoms of depression increase mortality risk after acute myocardial infarction |
| Q34200088 | Executive summary: a report of the Surgeon General on mental health |
| Q36399638 | Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study |
| Q34868966 | Exercise and the treatment of clinical depression in adults: recent findings and future directions |
| Q34379641 | Exercise rehabilitation of older patients with cardiovascular disease |
| Q40823024 | Extracardiac contributions to chest pain perception in patients 6 months after acute myocardial infarction |
| Q34795585 | Factors associated with cardiac rehabilitation attendance: a systematic review of the literature. |
| Q58571774 | Factors associated with depressive symptoms in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A prospective cohort study |
| Q51123489 | Forebrain involvement in fatal cardiac arrhythmia |
| Q93012133 | Frequency of breakfast consumption is inversely associated with the risk of depressive symptoms among Chinese university students: A cross-sectional study |
| Q36134021 | Frequency of depression among patients with acute coronary syndrome, eastern region, saudi arabia |
| Q36675754 | Functional illness in primary care: dysfunction versus disease |
| Q51980082 | Functional limitations and survival following stroke: psychological and clinical predictors of 3-year outcome. |
| Q50923006 | Functional status in coronary artery disease: a one-year prospective study of the role of anxiety and depression. |
| Q36792774 | Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look |
| Q43777303 | Gender Differences in Psychosocial Issues Affecting Low-Income, Underserved Patients' Ability to Manage Cardiovascular Disease |
| Q33958371 | Gender and psychosomatic aspects of ischemic heart disease. |
| Q48718637 | Gender differences in emotional disability and negative health perception in cardiac patients 6 months after stent implantation |
| Q34412931 | Gender differences in fatigue associated with acute myocardial infarction |
| Q78556247 | Gender differences in the management and survival of patients with acute myocardial infarction |
| Q51983255 | Glycemic control and major depression in patients with type 1 and type 2 diabetes mellitus. |
| Q42553707 | Going home after a heart attack. Depression is also a risk factor |
| Q38987928 | Growing Relevance of Cardiac Rehabilitation for an Older Population With Heart Failure. |
| Q36046601 | Health care professionals in a heart failure team |
| Q46129009 | Health care use in depressed, elderly, cardiac patients and the effect of antidepressant use. |
| Q47750495 | Heart Rate Recovery After Exercise in Outpatients with Coronary Heart Disease: Role of Depressive Symptoms and Positive Affect. |
| Q35520767 | Heart and mind: (1) relationship between cardiovascular and psychiatric conditions |
| Q51924759 | Heart rate variability at rest and during mental stress in patients with coronary artery disease: differences in patients with high and low depression scores. |
| Q37400361 | Heart rate variability in depressed elderly |
| Q33952767 | Heart rate variability measurement and clinical depression in acute coronary syndrome patients: narrative review of recent literature |
| Q38021672 | Heartache and heartbreak--the link between depression and cardiovascular disease |
| Q37288199 | Heterogeneity in randomized controlled trials of long chain (fish) omega-3 fatty acids in restenosis, secondary prevention and ventricular arrhythmias |
| Q35608066 | High sensitivity C reactive protein, fibrinogen levels and the onset of major depressive disorder in post-acute coronary syndrome |
| Q24801271 | Home-based versus hospital-based cardiac rehabilitation after myocardial infarction or revascularisation: design and rationale of the Birmingham Rehabilitation Uptake Maximisation Study (BRUM): a randomised controlled trial [ISRCTN72884263] |
| Q51081769 | Hostility in marital dyads: associations with depressive symptoms. |
| Q52279809 | Hostility, testosterone, and vascular reactivity to stress: effects of sex. |
| Q41519173 | How Safe Are Serotonin Reuptake Inhibitors for Depression in Patients with Coronary Heart Disease? |
| Q37738400 | How late-life depression affects cognition: neural mechanisms |
| Q51112332 | Identification and treatment of psychosocial risk factors for coronary artery disease. |
| Q52006854 | Identification, course, and treatment of depression after admission for a cardiac condition: rationale and patient characteristics for the Identifying Depression As a Comorbid Condition (IDACC) project. |
| Q51761592 | Impact of Aging on the Auditory System and Related Cognitive Functions: A Narrative Review. |
| Q25255879 | Impact of briefly-assessed depression on secondary prevention outcomes after acute coronary syndrome: a one-year longitudinal survey. |
| Q34817485 | Impact of depression on sex differences in outcome after myocardial infarction |
| Q28207272 | Impact of major depression on chronic medical illness |
| Q35772818 | Impact of medical comorbid disease on antidepressant treatment of major depressive disorder |
| Q37667586 | Impact of psychosocial risk factors on the heart: changing paradigms and perceptions |
| Q34724644 | Improving psychologic adjustment to chronic illness in cardiac patients. The role of depression and anxiety |
| Q44188612 | Inadequate treatment of depression after myocardial infarction |
| Q37090820 | Incidence and Prognostic Significance of Depressive Symptoms in Peripheral Artery Disease |
| Q45805723 | Incidence of posttraumatic stress disorder (PTSD) after myocardial infarction (MI) and predictors of ptsd symptoms post-MI--a brief report |
| Q35542747 | Increased Coronary Events in Depressed Cardiovascular Patients: 5-HT2A Receptor as Missing Link? |
| Q35772504 | Increased Risk of Coronary Heart Disease in Patients with Primary Fibromyalgia and Those with Concomitant Comorbidity-A Taiwanese Population-Based Cohort Study |
| Q35946051 | Increased mortality in depressive disorders: a review |
| Q48119273 | Increased neuroplasticity may protect against cardiovascular disease |
| Q44722753 | Increased susceptibility to ventricular arrhythmias in a rodent model of experimental depression |
| Q46492419 | Independent and mediated contributions of personality, coping, social support, and depressive symptoms to physical functioning outcome among patients in cardiac rehabilitation |
| Q33873441 | Indications for treatment of asymptomatic carotid stenosis. |
| Q33773597 | Individual income, income inequality, health, and mortality: what are the relationships? |
| Q38131387 | Inflammation, heart disease, and depression |
| Q39004263 | Inflammation-Associated Co-morbidity Between Depression and Cardiovascular Disease |
| Q33962588 | Inflammatory protein levels and depression screening after coronary stenting predict major adverse coronary events |
| Q34958515 | Insulin resistance: a metabolic link between depressive disorder and atherosclerotic vascular diseases |
| Q30541872 | Integrating depression and chronic disease care among patients with diabetes and/or coronary heart disease: the design of the TEAMcare study |
| Q51088027 | Intensive rehabilitation of emotionally distressed patients after coronary by-pass grafting. |
| Q73502236 | Investigating the role of lipids in mood, aggression, and schizophrenia |
| Q46000837 | Invited Commentary: Stress and Mortality. |
| Q64092036 | Is depression a real risk factor for acute myocardial infarction mortality? A retrospective cohort study |
| Q36921109 | Is early- and late-onset depression after acute myocardial infarction associated with long-term survival in older adults? A population-based study |
| Q34159419 | Is the efficacy of psychopharmacological drugs comparable to the efficacy of general medicine medication? |
| Q34072827 | Is there a high-risk subtype of depression in patients with coronary heart disease? |
| Q33941211 | Joint modeling of longitudinal changes in depressive symptoms and mortality in a sample of community-dwelling elderly people |
| Q35582366 | Lack of a close confidant, but not depression, predicts further cardiac events after myocardial infarction |
| Q45947824 | Lactobacillus helveticus and Bifidobacterium longum taken in combination reduce the apoptosis propensity in the limbic system after myocardial infarction in a rat model. |
| Q48768747 | Levels of anxiety, depression and denial in patients with myocardial infarction |
| Q51945152 | Life satisfaction in patients with chest pain subsequently diagnosed as coronary heart disease--connection through depressive symptoms? |
| Q44233739 | Life-time history of suicide attempts and coronary artery disease in a community-dwelling elderly population |
| Q44106634 | Links between body mass index, total body fat, cholesterol, high-density lipoprotein, and insulin sensitivity in patients with obesity related to depression, anger, and anxiety |
| Q77661735 | Living the healthy heart path. Rehabilitation after a cardiac event |
| Q38832916 | Loneliness and cardiovascular disease and the role of late-life depression |
| Q47414227 | Long-term mental health of women after a first acute myocardial infarction |
| Q34084135 | Longitudinal course of depressive symptomatology after a cardiac event: effects of gender and cardiac rehabilitation |
| Q41333390 | Major depression in the primary care setting |
| Q44145409 | Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on long-term heart rate variability measures |
| Q52222206 | Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease. |
| Q35794692 | Making advances where it matters: improving outcomes in mood and anxiety disorders. |
| Q41333395 | Making the diagnosis of depression in the primary care setting |
| Q33921959 | Management of comorbid depression and heart disease: the time has (almost) come |
| Q34384552 | Management of depression in patients with coronary heart disease: association, mechanisms, and treatment implications for depressed cardiac patients |
| Q40977726 | Management of depression in the outpatient office |
| Q79968581 | Managing depression in primary care: achieving remission |
| Q40645304 | Measuring costs of guideline-driven mental health care: the Texas Medication Algorithm Project |
| Q36777798 | Measuring patient-reported outcomes in solid organ transplant recipients: an overview of instruments developed to date |
| Q36995719 | Mechanisms underlying altered mood and cardiovascular dysfunction: the value of neurobiological and behavioral research with animal models |
| Q51979727 | Med Psych Units: Proceedings and abstracts of the Triptych Workshop 9 december 1999 Maastricht. |
| Q41678338 | Medical and Economic Costs of Psychologic Distress in Patients With Coronary Artery Disease |
| Q34786784 | Medical comorbidity and late life depression: what is known and what are the unmet needs? |
| Q34996459 | Mediterranean diet mediates the adverse effect of depressive symptomatology on short-term outcome in elderly survivors from an acute coronary event |
| Q43650394 | Mending broken hearts: marriage and survival following cardiac surgery |
| Q48699320 | Mental disorders and medical conditions. A community study in a small island in Spain |
| Q37385194 | Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap |
| Q37429971 | Mind and body reunited: improving care at the behavioral and primary healthcare interface |
| Q34633241 | Mood disorders and chronic obstructive pulmonary disease: current research and future needs |
| Q51005377 | Mood disturbance in patients with recurrent ventricular dysrhythmia before insertion of implantable cardioverter defibrillator. |
| Q36528666 | Mood, anxiety, and physical illness: body and mind, or mind and body? |
| Q47581098 | Mortality and depressive symptoms in inhabitants of residential homes |
| Q42714613 | Myocardial infarction and risk of suicide: another reason to develop and test ways to reduce distress in postmyocardial-infarction patients? |
| Q35066565 | Negative emotion and coronary heart disease. A review |
| Q51116280 | Negative emotions and coronary heart disease: getting to the heart of the matter. |
| Q42696477 | Neuro-Coagulopathy: Blood Coagulation Factors in Central Nervous System Diseases |
| Q59808647 | Neuro-Immune Hemostasis: Homeostasis and Diseases in the Central Nervous System |
| Q33639042 | Neurobehavioural sequelae of cardiopulmonary bypass |
| Q48427552 | Neuroendocrine and immune system interactions in stress and depression |
| Q33872507 | Neurohormonal and inflammatory hyper-responsiveness to acute mental stress in depression |
| Q37766749 | Neuropsychiatric complications of chronic kidney disease |
| Q37111596 | New frontiers in cardiovascular behavioral medicine: comparative effectiveness of exercise and medication in treating depression |
| Q57635945 | Non-invasive management of coronary artery disease |
| Q33671337 | Older patients' views on the relationship between depression and heart disease. |
| Q51943038 | One year cumulative incidence of depression following myocardial infarction and impact on cardiac outcome. |
| Q39269667 | Optimism and death: predicting the course and consequences of depression trajectories in response to heart attack |
| Q35020636 | Oscillometric measure of blood pressure detects association between orthostatic hypotension and depression in population based study of older adults |
| Q78169448 | Panic disorder patients and their medical care |
| Q32097634 | Paroxetine versus nortriptyline in the continuation and maintenance treatment of depression in the elderly |
| Q47340487 | Pathogenesis of depression- and anxiety-like behavior in an animal model of hypertrophic cardiomyopathy |
| Q34655157 | Pathophysiological basis of cardiovascular disease and depression: a chicken-and-egg dilemma |
| Q34744698 | Patient-centered processes of care and long-term outcomes of myocardial infarction |
| Q37793364 | Peculiarities of Geriatric Psychiatry: A Focus on Aging and Depression |
| Q58301438 | Perceived stress is associated with CD4+ cell decline in men and women living with HIV/AIDS in Spain |
| Q34388376 | Persistent comorbid symptoms of depression and anxiety predict mortality in heart disease |
| Q77935226 | Platelet cytosolic calcium hyperresponsivity to serotonin in patients with hypertension and depressive symptoms |
| Q51098793 | Platelet cytosolic calcium responses to serotonin in depressed patients and controls: relationship to symptomatology and medication. |
| Q37195327 | Platelets and depression in cardiovascular disease: A brief review of the current literature |
| Q48440447 | Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism |
| Q86678550 | Positive and negative affect in rheumatoid arthritis: Increased specificity in the assessment of emotional adjustment |
| Q89537314 | Post-Stroke Depression and Estimated Glomerular Filtration Rate: A Prospective Stroke Cohort |
| Q57696634 | Post-traumatic Growth among Cardiac Outpatients |
| Q77456493 | Potential intervention for depression associated with increased mortality risk in patients after myocardial infarction |
| Q48530561 | Predicting depression from illness severity in cardiovascular disease patients: self-efficacy beliefs, illness perception, and perceived social support as mediators. |
| Q48048761 | Predictors of Poor Response to Depression Treatment in Primary Care |
| Q46343329 | Predictors of depressive symptoms post-acute coronary syndrome |
| Q34983057 | Predictors of physical and mental health-related quality of life outcomes among myocardial infarction patients |
| Q40897223 | Predictors of quality of life after hospital admission for heart attack or angina |
| Q36916368 | Preoperative anxiety as a predictor of mortality and major morbidity in patients aged >70 years undergoing cardiac surgery |
| Q35653775 | Prevalence and characteristics of multiple psychiatric disorders in cardiac rehabilitation patients |
| Q74597021 | Prevalence and effects of cardiac rehabilitation on depression in the elderly with coronary heart disease |
| Q36216773 | Prevalence and risk factors for depression among community resident older people in Kerala |
| Q43999798 | Prevalence of depression in congestive heart failure |
| Q64113329 | Prevalence of depression in myocardial infarction: A PRISMA-compliant meta-analysis |
| Q34704102 | Prevalence of depression in survivors of acute myocardial infarction. |
| Q35533430 | Prevalence of major depressive episode in CKD. |
| Q48703317 | Primary care medical provider attitudes regarding mental health and behavioral medicine in integrated and non-integrated primary care practice settings |
| Q89258969 | Prioritization, Development, and Validation of American Association of Cardiovascular and Pulmonary Rehabilitation Performance Measures |
| Q28195456 | Process of care and outcome after acute myocardial infarction for patients with mental illness in the VA health care system: are there disparities? |
| Q39424935 | Prognostic Utility of a Self-Reported Depression Questionnaire versus Clinician-Based Assessment on Renal Outcomes |
| Q48957291 | Psychiatric Aspects of Heart and Lung Disease in Critical Care |
| Q41151389 | Psychiatric aspects of cardiovascular disease |
| Q34023397 | Psychiatric assessment in transplantation |
| Q40929269 | Psychiatric interventions in the medically ill. Outcome and effectiveness research |
| Q52006597 | Psychiatry in medical practice. Implications for the education of primary care physicians in the era of managed care: Part 1. |
| Q40915902 | Psychiatry in medical practice. Implications for the education of primary care physicians in the era of managed care: Part 2. |
| Q71944949 | Psychologic Factors and Course After Myocardial Infarction: Maturing of a Risk Factor |
| Q33958326 | Psychological factors affecting a medical condition: ischemic coronary heart disease |
| Q24244818 | Psychological interventions for depression in heart failure |
| Q46220361 | Psychological risk factors for HIV pathogenesis: mediation by the autonomic nervous system |
| Q44009418 | Psychological risk factors for increased post-operative length of hospital stay following coronary artery bypass graft surgery. |
| Q31107810 | Psychometric properties of the cardiac depression scale in patients with coronary heart disease |
| Q74839600 | Psychopathology following cardioverter defibrillator implantation |
| Q46179552 | Psychosocial and cultural influences on cardiovascular health and quality of life among Hispanic cardiac patients in South Florida |
| Q43593143 | Psychosocial and reported inflammatory disease correlates of self-reported heart disease in women from South of Israel. |
| Q41380374 | Psychosocial aspects of coronary artery disease related to military patients |
| Q34171374 | Psychosocial assessments and outcomes in organ transplantation |
| Q41386411 | Psychosocial factors: role in cardiac risk and treatment strategies |
| Q36650717 | Psychosocial outcomes of an exercise maintenance intervention after phase II cardiac rehabilitation |
| Q39689867 | Public awareness about the connection between depression and physical health: specifically heart disease |
| Q33567392 | Quality and customers: Type 2 change in mental health delivery within health care reform |
| Q36136274 | Quality of life and baseline characteristics associated with depressive symptoms among patients with heart disease |
| Q53569198 | Quality of life and later adverse health outcomes in patients with suspected heart attack. |
| Q35673080 | Quality of life in geriatric patients with mood and anxiety disorders. |
| Q53650697 | Racial and ethnic disparities in depression care in community-dwelling elderly in the United States. |
| Q40883680 | Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction. |
| Q73744990 | Randomized trial of a noninvasive strategy to reduce hospital stay for patients with low-risk myocardial infarction |
| Q35772687 | Rapid screening for major depression in post-myocardial infarction patients: an investigation using Beck Depression Inventory II items |
| Q48577505 | Raymond Prince: reflections on his career contributions to transcultural psychiatry |
| Q30513777 | Real-world lessons from the implementation of a depression screening protocol in acute myocardial infarction patients: implications for the American Heart Association depression screening advisory |
| Q33589056 | Recognition of depression by primary care clinicians in rural Ethiopia |
| Q77323964 | Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study |
| Q51088085 | Relation between myocardial infarction, depression, hostility, and death. |
| Q40001290 | Relationship between forgiveness and psychological and physiological indices in cardiac patients |
| Q34122935 | Relationship between hair cortisol concentrations and depressive symptoms in patients with coronary artery disease |
| Q43836198 | Religion and medicine III: developing a theoretical model |
| Q43039392 | Resolvin D1, a metabolite of omega-3 polyunsaturated fatty acid, decreases post-myocardial infarct depression |
| Q47128198 | Return to Work and Risk of Subsequent Detachment From Employment After Myocardial Infarction: Insights From Danish Nationwide Registries |
| Q35551130 | Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction |
| Q41702163 | Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression |
| Q28084482 | Role of Heart and its Diseases in the Etiology of Depression According to Avicenna's Point of View and its Comparison with Views of Classic Medicine |
| Q34911339 | Role of depression in outcomes of endoscopic sinus surgery |
| Q35558259 | Role of peripheral vascular resistance for the association between major depression and cardiovascular disease |
| Q82093200 | Role of psycho-social factors in CVD |
| Q57128257 | ST segment elevation myocardial infarction (STEMI) patients are more likely to achieve lipid-lowering treatment goals: A retrospective analysis of patients presenting with first acute coronary syndromes |
| Q37137359 | Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure |
| Q55715533 | Screening Cardiovascular Risk in Patients with High Depression Scores. |
| Q39951196 | Screening for Major Depression in Post-Myocardial Infarction Patients: Operating Characteristics of the Beck Depression Inventory-II |
| Q33501712 | Screening for affective and anxiety disorders in medical patients - comparison of HADS, GHQ-12 and Brief-PHQ. |
| Q45226621 | Screening for mental disorders in cancer, cardiovascular and musculoskeletal diseases. Comparison of HADS and GHQ-12. |
| Q46527133 | Screening for mental disorders in cardiology outpatients |
| Q52614453 | Selective serotonin reuptake inhibitor use and outcomes following cardiac surgery-a systematic review. |
| Q34273647 | Selective serotonin reuptake inhibitors for late-life depression: a comparative review |
| Q43228767 | Selective serotonin reuptake inhibitors provide significant lower re-hospitalization rates in patients recovering from acute coronary syndromes: evidence from a meta-analysis |
| Q46746745 | Sertraline treatment for depression associated with acute coronary syndromes: a cost analysis from the viewpoint of the Italian Healthcare System |
| Q36264376 | Serum cortisol, immunoglobulins and some complements among depressed patients |
| Q73954790 | Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease |
| Q91458297 | Sex differences and the prognosis of depressive and nondepressive patients with cardiovascular risk factors: the Japan Morning Surge-Home Blood Pressure (J-HOP) study |
| Q45271059 | Sex differences in predictors of illness intrusiveness 1 year after a cardiac event |
| Q33971187 | Sexual activity and cardiac risk: is depression a contributing factor? |
| Q34707312 | Sexual dysfunction and depression: etiology, prevalence, and treatment |
| Q34577817 | Shortness of breath as a predictor of depressive symptoms in a community sample of older adults |
| Q35772824 | Should selective serotonin reuptake inhibitors be prescribed to all patients with ischemic heart disease? |
| Q35411616 | Social inequalities in depressive symptoms and physical functioning in the Whitehall II study: exploring a common cause explanation |
| Q74628946 | Socioeconomic status, social environment, depression and postdischarge adjustment of the cardiac patient |
| Q34053693 | Somatic presentation of psychiatric morbidity in general practice |
| Q44787892 | Spousal depression, anxiety, and suicide after myocardial infarction |
| Q37035595 | Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models |
| Q26825298 | Study exploring depression and cardiovascular diseases amongst Arabic speaking patients living in the State of Qatar: Rationale and methodology |
| Q53083514 | Survey of general practitioners' attitudes to prescribing statins in different patient groups: a web-based survey. |
| Q37375134 | Tai chi chuan exercise for patients with cardiovascular disease. |
| Q34675464 | Targeted versus tailored multimedia patient engagement to enhance depression recognition and treatment in primary care: randomized controlled trial protocol for the AMEP2 study |
| Q36229948 | Temperament affects sympathetic nervous function in a normal population |
| Q36532265 | Temperament and Character Profiles and Psychiatric Comorbidities in Patients With Coronary Artery or Valvular Heart Disease: Relationship With Cardiac Disease Severity |
| Q36627848 | Testing therapeutic life review offered by home care workers to decrease depression among home-dwelling older women |
| Q43235357 | The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management |
| Q40262068 | The Association Between Air Pollution and Onset of Depression Among Middle-Aged and Older Women |
| Q24682953 | The Comorbidity of Major Depression and Anxiety Disorders: Recognition and Management in Primary Care |
| Q37033684 | The Impact of Red Blood Cell Distribution Width and Neutrophil/Lymphocyte Ratio on the Diagnosis of Major Depressive Disorder |
| Q47573931 | The Population Mean Mood Predicts The Prevalence of Depression in an Australian Context. |
| Q56928582 | The Relationship between Self-Rated Health and Health Status among Coronary Artery Patients |
| Q55256132 | The Role of Illness Perception and Its Association With Posttraumatic Stress at 3 Months Following Acute Myocardial Infarction. |
| Q34980524 | The St. Louis African American health-heart study: methodology for the study of cardiovascular disease and depression in young-old African Americans |
| Q77050993 | The added costs of depression to medical care |
| Q34081684 | The association among depressive symptoms, smoking status and antidepressant use in cardiac outpatients |
| Q36779786 | The association between insomnia and cardiovascular diseases |
| Q52003249 | The association of lifetime psychiatric illness and increased retinopathy in patients with type I diabetes mellitus. |
| Q37584098 | The broad spectrum of comorbid depression: implications for treatment |
| Q48321693 | The clinical epidemiology of depression in palliative care and the predictive value of somatic symptoms: cross-sectional survey with four-week follow-up |
| Q35251998 | The cognitive profile of depressed patients with cirrhosis |
| Q51975534 | The collaboration between psychiatry and primary care in managed care. |
| Q34765089 | The effect of a charted history of depression on emergency department triage and outcomes in patients with acute myocardial infarction |
| Q34538100 | The effect of antidepressants on lipid homeostasis: a cardiac safety concern? |
| Q36300227 | The effect of depression on stage at diagnosis, treatment, and survival in pancreatic adenocarcinoma |
| Q51986687 | The effect of major depression on functional status in patients with coronary artery disease. |
| Q36318602 | The effect of the US Medicare Part D coverage gaps on medication use among patients with depression and heart failure |
| Q33942251 | The effects of a tailored cardiac rehabilitation program on depressive symptoms in women: A randomized clinical trial |
| Q34108590 | The effects of depression, stressful life events, social support, and coping on the progression of HIV infection |
| Q37793599 | The effects of statins on mood: a review of the literature |
| Q47610833 | The feeling of loneliness prior to coronary artery bypass grafting might be a predictor of short-and long-term postoperative mortality |
| Q34075317 | The impact of angina and cardiac history on health-related quality of life and depression in coronary heart disease patients |
| Q44797860 | The impact of gender on early ill-health retirement in people with heart disease and depression. |
| Q27028208 | The impact of premorbid and postmorbid depression onset on mortality and cardiac morbidity among patients with coronary heart disease: meta-analysis |
| Q36327263 | The impact of residual symptoms on outcome of major depression |
| Q34043602 | The impact of vascular burden on late-life depression |
| Q40447927 | The interaction between erectile dysfunction complaints and depression in men: a cross-sectional study about sleep, hormones and quality of life. |
| Q35846515 | The interdependence of behavioral and somatic health: implications for conceptualizing health and measuring treatment outcomes. |
| Q40748319 | The long-term risk of recognized and unrecognized myocardial infarction for depression in older men. |
| Q41127960 | The management of treatment-resistant depression in the medically ill. |
| Q33971194 | The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction |
| Q37308600 | The overlap syndrome of depression and delirium in older hospitalized patients. |
| Q35236630 | The pharmacological management of depression |
| Q35940440 | The predictive power of depression screening procedures for veterans with coronary artery disease |
| Q51979559 | The psychiatric profile of patients with chronic diseases who do not receive regular medical care. |
| Q73742444 | The psychological consequences of cardiopulmonary resuscitation training for family members of patients at risk for sudden death |
| Q35560792 | The public health impact of major depression: a call for interdisciplinary prevention efforts |
| Q33351796 | The puzzle of depression and acute coronary syndrome: reviewing the role of acute inflammation |
| Q51994435 | The relationship between admission to hospital with chest pain and psychiatric disorder. |
| Q33868089 | The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes |
| Q33725124 | The relationship between major depression and nonsuicide mortality for U.S. adults: the importance of health behaviors |
| Q35844284 | The relationship between subtypes of depression and cardiovascular disease: a systematic review of biological models |
| Q40477962 | The relationship between vital exhaustion, depression and comorbid illnesses in patients following first myocardial infarction. |
| Q37377390 | The role of L-methylfolate in depressive disorders. |
| Q33768249 | The role of bipolarity in depression in the family practice setting |
| Q37484246 | The role of cardiovascular disease in the identification and management of depression by primary care physicians. |
| Q48624697 | The role of depressive and anxiety symptoms in the evaluation of cardiac rehabilitation efficacy after coronary artery bypass grafting surgery. |
| Q47260314 | The role of immune abnormality in depression and cardiovascular disease |
| Q33605177 | The role of medical comorbidity in outcome of major depression in primary care: the PROSPECT study |
| Q36691552 | The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity |
| Q34655466 | The significance of depression in older patients after myocardial infarction |
| Q51905223 | The store front, Fountain House, and the rehabilitation alliance. |
| Q44798249 | The symptom profile of vascular depression |
| Q35761345 | Timing of depressive symptom onset and in-hospital complications among acute coronary syndrome inpatients |
| Q72167576 | Timing of referral of terminally ill patients to an outpatient hospice |
| Q34731461 | Trajectories of depressive episodes and hypertension over 24 years: the Whitehall II prospective cohort study |
| Q63979205 | Treating depression and anxiety in primary care |
| Q33646917 | Treating depression in patients with ischaemic heart disease: which agents are best to use and to avoid? |
| Q33699764 | Treatment of Stable Angina Pectoris |
| Q35899447 | Treatment of affective disorders in cardiac disease |
| Q38072000 | Treatment of depression in cardiovascular disease |
| Q41544410 | Treatment of major depression in later life: a life cycle perspective |
| Q34982300 | Treatment of mood disorders |
| Q37203368 | Treatment of post-myocardial infarction depressive disorder |
| Q34695996 | Type 2 diabetes does not increase risk of depression |
| Q36914846 | Understanding prognostic benefits of exercise and antidepressant therapy for persons with depression and heart disease: the UPBEAT study--rationale, design, and methodological issues |
| Q33588350 | Update in internal medicine |
| Q36102214 | Use of antidepressants in older patients with co-morbid medical conditions: guidance from studies of depression in somatic illness |
| Q37152585 | Use of the hospital anxiety and depression scale (HADS) in a cardiac emergency room: chest pain unit |
| Q33682934 | Using a Bayesian latent growth curve model to identify trajectories of positive affect and negative events following myocardial infarction |
| Q53245361 | Validating a self-report measure of global subjective well-being to predict adverse clinical outcomes. |
| Q37152050 | Vascular factors and depression |
| Q43024774 | Vulnerability for apoptosis in the limbic system after myocardial infarction in rats: a possible model for human postinfarct major depression. |
| Q33856140 | What are the causes of late-life depression? |
| Q40918652 | What does the beck depression inventory measure in myocardial infarction patients? a psychometric approach using item response theory and person-fit. |
| Q51037676 | Women's hearts need special treatment. |
| Q83634311 | [Depression in restless legs syndrome. Pathogenesis, assessment, and implications for treatment] |
| Q74729489 | [Depression, anxiety and cardiovascular disease: biological correlations and therapeutic strategies] |
| Q52886263 | [Depression: risk factor for cardiovascular disease]. |
| Q53522593 | [Personality and comorbidity: are there "difficult patients" in hip arthroplasty?]. |
| Q84630586 | [Psychosomatic aspects of cardiac arrhythmias] |
| Q73714731 | [Sociologic overview of quality life] |
| Q74042696 | [The detection of mental disorders by physicians who are not psychiatrists: usefulness of the PRIME-MD questionnaire] |
| Q44905548 | p38 MAP kinase inhibitor reverses stress-induced cardiac myocyte dysfunction |